![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Nonsteroidal anti-inflammatory drugs are widely used for systemic control of acute or chronic pain and inflammation. Topical ophthalmic NSAIDs are used to treat ocular surface and anterior segment inflammation as well as postoperative management of pain and inflammation. Bromfenac ophthalmic solution 0.09% is rapidly becoming a widely prescribed topical ophthalmic within its class. Bromfenac has an extensive global safety record as an anti-inflammatory drug, as well as in the management of ocular pain and inflammation following cataract and refractive surgery and corneal abrasions. Bromfenac’s unique chemical structure makes it both a potent anti-inflammatory drug and a lipophilic molecule that penetrates ocular tissues, ensuring sustained drug levels in all ocular tissues for over 24 h.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.